back-office Open An Account
partner-with-us Partner with Us
Corporate Actions
Anuh Pharma gains after inaugurating new manufacturing block in Maharashtra

15-Jul-25   15:10 Hrs IST
In a regulatory filing, the company stated that the new facility is expected to become operational within July 2025. Upon commencement, the plant will expand Anuh Pharma's manufacturing capacity by an additional 200 metric tons per annum (MT/Annum).

Post-expansion, the company's total production capacity will increase from approximately 2,200 MT/Annum to 2,400 MT/Annum.

The newly inaugurated INT-1A block is also equipped with an additional 40 kiloliters (KL) of reactor capacity, enhancing the company's infrastructure and positioning it to meet growing market demand more effectively.

Anuh Pharma, a bulk drug manufacturing company, is part of the Rs 8.5 bn SK Group of Companies, which employs 2000+ people across businesses such as manufacturing of APIs, pharma formulations, distribution, and logistics. Established in 1960, Anuh Pharma today is one of the largest manufacturers of macrolides and anti-TB products in India, besides being a major player in anti-bacterials, anti-malarials, and corticosteroids.

The company's standalone net profit fell 18.9% to Rs 12.46 crore, while revenue from operations jumped 20.9% to Rs 198.14 crore in Q4 March 2025 over Q4 March 2024.

Powered by Capital Market - Live News

Attention Investors: Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.|| KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.|| No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.